Caravel Bio secures $1.2M NSF Phase II grant to advance biomolecular engineering platform for protein design with new-to-nature chemistries.
Amount Raised
$1.2 Million
Round Type
Grant
PortlandBiotechnologyInvestors
Description
Caravel Bio, a Portland, OR-based biomolecular engineering platform provider, received a $1.2M NSF Phase II grant. The funds will support development of a system for creating and scaling proteins with new-to-nature chemistries, scaling machine learning datasets, and extending the platform to additional enzyme classes. The company will execute real-world pilots for customers in DNA writing, carbon capture, and rare earth separations. Caravel Bio's platform combines cell-free protein synthesis, microfluidic droplets, and bacterial spore display to enable discovery and design of novel proteins.
Who to call at Caravel Bio, and when
A new round usually means Caravel Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Caravel Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Caravel Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Caravel Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Caravel Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Caravel Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.